Report Description Request For TOC Research Methodology Download Free Sample

Market Snapshot

CAGR:9.42

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	9.42

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

Personalized medicine is at an early stage of development. Scientists found that some cancer cells have particular proteins in the cell and others don't. Sometimes, cancer cells have far more of a particular protein than healthy cells. Genetic testing of cancer cells and normal cells helps doctors customize treatment to individual patient needs. Personalized treatments may cause fewer side effects than standard options. Some people are already benefiting from this approach.
In 2018, the global Personalized Cancer Medicine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2026, with a CAGR of xx% during 2019-2026.

This report focuses on the global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Cancer Medicine development in United States, Europe and China.

The key players covered in this study
Abbott
Merck
Novartis
Amgen
Celgene
Bayer
Roche
Astellas
Astrazeneca
Johnson & Johnson
Agilent
Takeda

Market segment by Type, the product can be split into
Monoclonal Antibodies
Personalized Cancer Vaccines
Other

Market segment by Application, split into
Breast Cancer
Lung Cancer
Chronic Myeloid Leukaemia
Bowel Cancer
Other Cancer

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Personalized Cancer Medicine status, future forecast, growth opportunity, key market and key players.
To present the Personalized Cancer Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Personalized Cancer Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalized Cancer Medicine Market Size Growth Rate by Type (2014-2025)
1.4.2 Monoclonal Antibodies
1.4.3 Personalized Cancer Vaccines
1.4.4 Other
1.5 Market by Application
1.5.1 Global Personalized Cancer Medicine Market Share by Application (2014-2025)
1.5.2 Breast Cancer
1.5.3 Lung Cancer
1.5.4 Chronic Myeloid Leukaemia
1.5.5 Bowel Cancer
1.5.6 Other Cancer
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Personalized Cancer Medicine Market Size
2.2 Personalized Cancer Medicine Growth Trends by Regions
2.2.1 Personalized Cancer Medicine Market Size by Regions (2014-2025)
2.2.2 Personalized Cancer Medicine Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Personalized Cancer Medicine Market Size by Manufacturers
3.1.1 Global Personalized Cancer Medicine Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalized Cancer Medicine Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalized Cancer Medicine Market Concentration Ratio (CR5 and HHI)
3.2 Personalized Cancer Medicine Key Players Head office and Area Served
3.3 Key Players Personalized Cancer Medicine Product/Solution/Service
3.4 Date of Enter into Personalized Cancer Medicine Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Personalized Cancer Medicine Market Size by Type (2014-2019)
4.2 Global Personalized Cancer Medicine Market Size by Application (2014-2019)

5 United States
5.1 United States Personalized Cancer Medicine Market Size (2014-2019)
5.2 Personalized Cancer Medicine Key Players in United States
5.3 United States Personalized Cancer Medicine Market Size by Type
5.4 United States Personalized Cancer Medicine Market Size by Application

6 Europe
6.1 Europe Personalized Cancer Medicine Market Size (2014-2019)
6.2 Personalized Cancer Medicine Key Players in Europe
6.3 Europe Personalized Cancer Medicine Market Size by Type
6.4 Europe Personalized Cancer Medicine Market Size by Application

7 China
7.1 China Personalized Cancer Medicine Market Size (2014-2019)
7.2 Personalized Cancer Medicine Key Players in China
7.3 China Personalized Cancer Medicine Market Size by Type
7.4 China Personalized Cancer Medicine Market Size by Application

8 Japan
8.1 Japan Personalized Cancer Medicine Market Size (2014-2019)
8.2 Personalized Cancer Medicine Key Players in Japan
8.3 Japan Personalized Cancer Medicine Market Size by Type
8.4 Japan Personalized Cancer Medicine Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Personalized Cancer Medicine Market Size (2014-2019)
9.2 Personalized Cancer Medicine Key Players in Southeast Asia
9.3 Southeast Asia Personalized Cancer Medicine Market Size by Type
9.4 Southeast Asia Personalized Cancer Medicine Market Size by Application

10 India
10.1 India Personalized Cancer Medicine Market Size (2014-2019)
10.2 Personalized Cancer Medicine Key Players in India
10.3 India Personalized Cancer Medicine Market Size by Type
10.4 India Personalized Cancer Medicine Market Size by Application

11 Central & South America
11.1 Central & South America Personalized Cancer Medicine Market Size (2014-2019)
11.2 Personalized Cancer Medicine Key Players in Central & South America
11.3 Central & South America Personalized Cancer Medicine Market Size by Type
11.4 Central & South America Personalized Cancer Medicine Market Size by Application

12 International Players Profiles
12.1 Abbott
12.1.1 Abbott Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalized Cancer Medicine Introduction
12.1.4 Abbott Revenue in Personalized Cancer Medicine Business (2014-2019)
12.1.5 Abbott Recent Development
12.2 Merck
12.2.1 Merck Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalized Cancer Medicine Introduction
12.2.4 Merck Revenue in Personalized Cancer Medicine Business (2014-2019)
12.2.5 Merck Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalized Cancer Medicine Introduction
12.3.4 Novartis Revenue in Personalized Cancer Medicine Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Amgen
12.4.1 Amgen Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalized Cancer Medicine Introduction
12.4.4 Amgen Revenue in Personalized Cancer Medicine Business (2014-2019)
12.4.5 Amgen Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalized Cancer Medicine Introduction
12.5.4 Celgene Revenue in Personalized Cancer Medicine Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Bayer
12.6.1 Bayer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalized Cancer Medicine Introduction
12.6.4 Bayer Revenue in Personalized Cancer Medicine Business (2014-2019)
12.6.5 Bayer Recent Development
12.7 Roche
12.7.1 Roche Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalized Cancer Medicine Introduction
12.7.4 Roche Revenue in Personalized Cancer Medicine Business (2014-2019)
12.7.5 Roche Recent Development
12.8 Astellas
12.8.1 Astellas Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalized Cancer Medicine Introduction
12.8.4 Astellas Revenue in Personalized Cancer Medicine Business (2014-2019)
12.8.5 Astellas Recent Development
12.9 Astrazeneca
12.9.1 Astrazeneca Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalized Cancer Medicine Introduction
12.9.4 Astrazeneca Revenue in Personalized Cancer Medicine Business (2014-2019)
12.9.5 Astrazeneca Recent Development
12.10 Johnson & Johnson
12.10.1 Johnson & Johnson Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalized Cancer Medicine Introduction
12.10.4 Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2014-2019)
12.10.5 Johnson & Johnson Recent Development
12.11 Agilent
12.12 Takeda

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Personalized Cancer Medicine Key Market Segments
Table Key Players Personalized Cancer Medicine Covered
Table Global Personalized Cancer Medicine Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Personalized Cancer Medicine Market Size Market Share by Type 2014-2025
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Personalized Cancer Vaccines Figures
Table Key Players of Personalized Cancer Vaccines
Figure Other Figures
Table Key Players of Other
Table Global Personalized Cancer Medicine Market Size Growth by Application 2014-2025 (Million US$)
Figure Breast Cancer Case Studies
Figure Lung Cancer Case Studies
Figure Chronic Myeloid Leukaemia Case Studies
Figure Bowel Cancer Case Studies
Figure Other Cancer Case Studies
Figure Personalized Cancer Medicine Report Years Considered
Table Global Personalized Cancer Medicine Market Size 2014-2025 (Million US$)
Figure Global Personalized Cancer Medicine Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Personalized Cancer Medicine Market Size by Regions 2014-2025 (Million US$)
Table Global Personalized Cancer Medicine Market Size by Regions 2014-2019 (Million US$)
Table Global Personalized Cancer Medicine Market Share by Regions 2014-2019
Figure Global Personalized Cancer Medicine Market Share by Regions 2014-2019
Figure Global Personalized Cancer Medicine Market Share by Regions 2019
Table Market Top Trends
Table Global Personalized Cancer Medicine Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Personalized Cancer Medicine Market Share by Manufacturers (2014-2019)
Figure Global Personalized Cancer Medicine Market Share by Manufacturers in 2018
Table Global Personalized Cancer Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Personalized Cancer Medicine Product/Solution/Service
Table Date of Enter into Personalized Cancer Medicine Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table Global Personalized Cancer Medicine Market Size Share by Type (2014-2019)
Figure Global Personalized Cancer Medicine Market Size Market Share by Type (2014-2019)
Table Global Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table Global Personalized Cancer Medicine Market Size Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Market Size Market Share by Application (2014-2019)
Figure Global Personalized Cancer Medicine Revenue Market Share by Application in 2018
Figure United States Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table United States Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table United States Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table United States Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table United States Personalized Cancer Medicine Market Share by Type (2014-2019)
Table United States Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table United States Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure Europe Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table Europe Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table Europe Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table Europe Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table Europe Personalized Cancer Medicine Market Share by Type (2014-2019)
Table Europe Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table Europe Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure China Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table China Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table China Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table China Personalized Cancer Medicine Market Size by Type (2014-20189) (Million US$)
Table China Personalized Cancer Medicine Market Share by Type (2014-2019)
Table China Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table China Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure Japan Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table Japan Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table Japan Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table Japan Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table Japan Personalized Cancer Medicine Market Share by Type (2014-2019)
Table Japan Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table Japan Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure Southeast Asia Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table Southeast Asia Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Personalized Cancer Medicine Market Share by Type (2014-2019)
Table Southeast Asia Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure India Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table India Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table India Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table India Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table India Personalized Cancer Medicine Market Share by Type (2014-2019)
Table India Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table India Personalized Cancer Medicine Market Share by Application (2014-2019)
Figure Central & South America Personalized Cancer Medicine Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Personalized Cancer Medicine Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Personalized Cancer Medicine Market Share (2018-2019)
Table Central & South America Personalized Cancer Medicine Market Size by Type (2014-2019) (Million US$)
Table Central & South America Personalized Cancer Medicine Market Share by Type (2014-2019)
Table Central & South America Personalized Cancer Medicine Market Size by Application (2014-2019) (Million US$)
Table Central & South America Personalized Cancer Medicine Market Share by Application (2014-2019)
Table Abbott Company Details
Table Abbott Revenue in Personalized Cancer Medicine Business (2014-2019) (Million US$)
Figure Abbott Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Abbott Recent Development
Table Merck Company Details
Table Merck Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Merck Recent Development
Table Novartis Company Details
Table Novartis Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Novartis Recent Development
Table Amgen Company Details
Table Amgen Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Amgen Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Amgen Recent Development
Table Celgene Company Details
Table Celgene Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Celgene Recent Development
Table Bayer Company Details
Table Bayer Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Bayer Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Bayer Recent Development
Table Roche Company Details
Table Roche Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Roche Recent Development
Table Astellas Company Details
Table Astellas Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Astellas Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Astellas Recent Development
Table Astrazeneca Company Details
Table Astrazeneca Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Astrazeneca Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Astrazeneca Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Personalized Cancer Medicine Business (2014-2019)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Personalized Cancer Medicine Business (2014-2019)
Table Johnson & Johnson Recent Development
Table Agilent Company Details
Table Takeda Company Details
Table Global Personalized Cancer Medicine Market Size by Regions (Million US$) 2019-2025
Figure Global Personalized Cancer Medicine Market Size Share by Regions (2019-2025)
Figure Global Personalized Cancer Medicine Market Size Share by Regions in 2025
Figure United States Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure Europe Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure China Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure Japan Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure India Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Personalized Cancer Medicine Market Size Forecast (2019-2025)(Million USD)
Table Global Personalized Cancer Medicine Market Size by Product (2019-2025) (Million US$)
Figure Global Personalized Cancer Medicine Market Size by Product (2019-2025)
Figure Global Personalized Cancer Medicine Market Size by Product in 2025
Table Global Personalized Cancer Medicine Market Size by Application (2019-2025) (Million US$)
Figure Global Personalized Cancer Medicine Market Size by Application (2019-2025)
Figure Global Personalized Cancer Medicine Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Personalized Cancer Medicine Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032